Vimarsana
Biggest News Aggregation in the World

Page 7 - Solid Biosciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Solid Biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Solid Biosciences Today - Breaking & Trending Today

Annie and Ilan Ganot P'26 Share a Deeply Personal Journey into Bioscience Research - Vimarsana News

Annie and Ilan Ganot P'26 Share a Deeply Personal Journey into Bioscience Research

On November 29, Annie and Ilan Ganot P’26, co-founders of Solid Biosciences, a Boston-based biotechnology company, gave an inspiring presentation to the CA community. They shared how they are developing treatments for Duchenne muscular dystrophy, a progressive and life-limiting muscle-wasting disease that afflicts approximately 10,000 boys in the United States alone, including their son. The Ganots shared how they leveraged their expertise, networks, and unrelenting drive as parents and professionals to push boundaries in science and technology to improve the lives of patients living with Du...

Comparing Finch Therapeutics Group (NASDAQ:FNCH) and Solid Biosciences (NASDAQ:SLDB) - Vimarsana News

Comparing Finch Therapeutics Group (NASDAQ:FNCH) and Solid Biosciences (NASDAQ:SLDB)

Solid Biosciences (NASDAQ:SLDB – Get Free Report) and Finch Therapeutics Group (NASDAQ:FNCH – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends and risk. Profitability This table compares Solid Biosciences […]

Stocks to Watch: Getty Images, TherapeuticsMD, Solid Biosciences - Vimarsana News

Stocks to Watch: Getty Images, TherapeuticsMD, Solid Biosciences

By Denny Jacob Getty Images Holdings lowered its 2023 outlook, citing challenges ranging from strikes in Hollywood to a stronger dollar. Shares retreat 5.8%...

Solid Up 27% On Receiving FDA IND For SGT-003 - Vimarsana News

Solid Up 27% On Receiving FDA IND For SGT-003

Shares of Solid Biosciences Inc. (SLDB) are up 27% on Wednesday following the announcement of FDA clearance of its Investigational New Drug (IND) application for SGT-003, which is the company's latest gene therapy candidate for Duchenne Muscular Dystrophy (Duchenne).

Why Solid Biosciences Stock Is Climbing Today - Solid Biosciences (NASDAQ:SLDB) - Vimarsana News

Why Solid Biosciences Stock Is Climbing Today - Solid Biosciences (NASDAQ:SLDB)

Solid Biosciences Inc.